Selway, Caitlin A.
Collins, Carmel T.
Makrides, Maria
Sullivan, Thomas R.
,
Gibson, Robert A.
Penttila, Irmeli
McPhee, Andrew
Weyrich, Laura S.
Article History
Received: 12 May 2022
Revised: 30 November 2022
Accepted: 14 December 2022
First Online: 1 March 2023
Competing interests
: The treatment and control emulsion for the trial were donated by Clover Corporation, Australia. The company had no role in the study design or conduct; in the data collection, management, analysis, or interpretation; or in the preparation, review, or approval of any manuscripts arising from this study.
: Participant consent for the study was described in a previously published study (Collins et al.<sup>27</sup>).